1. Berezina, O.V., Vainer, A.S., Voropaeva, E.N., et al., The effect of mononucleotide substitutions in genes of folate cycle on the possible development of non-Hodgkin lymphomas, Sib. Med. Obozreniye, 2011, no. 3, pp. 22–26.
2. Kovalenko, S.P., Chasovnikova, O.B., Mitrofanov, D.V., et al., Molecular and genetic analysis as a method of modern oncology, Byull. Sib. Otd. Ross. Akad. Med. Nauk, 2008, no. 4(132), pp. 35–39.
3. Kondratovskiy, P.M., Dubikov, A.I., and Doroshevskaya, A.Yu., P53 protein pathway changes and their influence on chronic pathogenesis of lymphoproliferative diseases, Onkogematologiya, 2011, no. 3, pp. 65–75.
4. Poddubnaya, I.V., Treatment of indolen non-Hodgkin lymphomas, Prakt. Onkol., 2003, vol. 5, no. 3, pp. 203–208.
5. Birgander, R., Själander, A., Zhou, Z., et al., p53 Polymorphisms and haplotypes in nasopharyngeal cancer, Hum. Hered., 1996, vol. 46, no. 1, pp. 49–54.